Suraksha Diagnostic Ltd. (IN:SURAKSHA)
:SURAKSHA
Want to see IN:SURAKSHA full AI Analyst Report?
SURAKSHA Stock Chart & Stats
₹300.85
-₹13.40(-3.48%)
At close: 4:00 PM EST
₹300.85
-₹13.40(-3.48%)
Day’s Range― - ―
52-Week Range₹224.10 - ₹353.65
Previous CloseN/A
Volume140.52K
Average Volume (3M)1.23K
Market Cap
₹13.95B
Enterprise Value₹15.10B
Total Cash (Recent Filing)₹435.94M
Total Debt (Recent Filing)₹1.18B
Price to Earnings (P/E)43.5
Beta1.13
Next Earnings
Aug 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)6.13
Shares Outstanding52,080,757
10 Day Avg. Volume1,073
30 Day Avg. Volume1,225
Financial Highlights & Ratios
PEG Ratio32.20
Price to Book (P/B)4.85
Price to Sales (P/S)3.82
P/FCF Ratio70.61
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)7.7
Revenue Forecast (FY)₹3.35B
Bulls Say, Bears Say
Bulls Say
Sustained Revenue GrowthMulti-year top-line expansion demonstrates durable demand for core diagnostic services and expanding market penetration. Consistent organic growth supports scale benefits, capacity utilization and predictable revenue base, aiding long-term planning and investment capacity over the next 2–6 months and beyond.
Healthy Operating ProfitabilityRelatively strong operating and EBITDA margins indicate efficient clinical operations and pricing power versus peers. Sustained margin bands provide cash earnings to fund reinvestment and absorb cost pressures, supporting structural profitability resilience if service mix and utilization remain stable.
Strong Operating Cash GenerationOperating cash conversion materially above accounting earnings reflects earnings quality and steady cash from core operations. Durable OCF helps fund working capital and capex needs without immediate financing, providing a structural cushion for reinvestment and near-term obligations.
Bears Say
Margin Compression & VolatilityMaterial gross- and net-margin declines signal pressure from pricing, cost inflation, or adverse product mix. Persistent margin weakness would erode operating leverage and reduce cash available for growth or deleveraging, challenging long-term return sustainability if not reversed.
Rising Leverage And Lower ReturnsIncreasing debt and falling ROE reduce financial flexibility and elevate default or refinancing risk in stress scenarios. Higher leverage raises interest burden and limits strategic optionality (M&A, capex), making the business more sensitive to macro shocks and margin pressure over the medium term.
Weak Free Cash Flow ConversionLow FCF conversion versus net income implies significant capex or working-capital absorption, limiting cash available for debt reduction, shareholder returns or strategic initiatives. Choppy FCF history increases uncertainty about the firm's ability to self-fund growth consistently.
Suraksha Diagnostic Ltd. News
SURAKSHA FAQ
What was Suraksha Diagnostic Ltd.’s price range in the past 12 months?
Suraksha Diagnostic Ltd. lowest stock price was ₹224.10 and its highest was ₹353.65 in the past 12 months.
What is Suraksha Diagnostic Ltd.’s market cap?
Suraksha Diagnostic Ltd.’s market cap is ₹13.95B.
When is Suraksha Diagnostic Ltd.’s upcoming earnings report date?
Suraksha Diagnostic Ltd.’s upcoming earnings report date is Aug 07, 2026 which is in 50 days.
How were Suraksha Diagnostic Ltd.’s earnings last quarter?
Suraksha Diagnostic Ltd. released its earnings results on May 21, 2026. The company reported ₹1.21 earnings per share for the quarter, beating the consensus estimate of N/A by ₹1.21.
Is Suraksha Diagnostic Ltd. overvalued?
According to Wall Street analysts Suraksha Diagnostic Ltd.’s price is currently Overvalued.
Does Suraksha Diagnostic Ltd. pay dividends?
Suraksha Diagnostic Ltd. does not currently pay dividends.
What is Suraksha Diagnostic Ltd.’s EPS estimate?
Suraksha Diagnostic Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Suraksha Diagnostic Ltd. have?
Suraksha Diagnostic Ltd. has 52,080,757 shares outstanding.
What happened to Suraksha Diagnostic Ltd.’s price movement after its last earnings report?
Suraksha Diagnostic Ltd. reported an EPS of ₹1.21 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 4.73%.
Which hedge fund is a major shareholder of Suraksha Diagnostic Ltd.?
Currently, no hedge funds are holding shares in IN:SURAKSHA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Suraksha Diagnostic Ltd.
Founded in Kolkata in 1992 as Suraksha Diagnostics & Eye Centre (P) Ltd., the company revolutionized diagnostic services in the city by being among the first to offer a full spectrum of pathology and radiology services under one roof. This integrated approach, coupled with an unwavering commitment to precision and patient care, led to consistent growth and widespread recognition. Within just three years, they expanded their footprint by opening a second center in Siliguri, North Bengal. This Siliguri facility continues to be the largest diagnostic center in the region, serving patients not only from North Bengal but also from neighboring states and countries. Since then, Suraksha Diagnostic Limited has continued its steady expansion, establishing a presence across Bengal, Bihar, and the Delhi National Capital Region.
Technical Analysis
Krsnaa Diagnostics Limited
―
Dr. Lal PathLabs Limited
―
Metropolis Healthcare Ltd.
―
Thyrocare Technologies Ltd
―
Vimta Labs Limited
―